Research Keyword: cognitive enhancement

Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence

Psychedelic drugs like LSD and psilocybin enhance creativity by disrupting the brain’s Default Mode Network, allowing people to break free from rigid thinking patterns. This paper proposes that artificial intelligence systems could be designed to mimic these same cognitive effects—introducing novel information, making unexpected connections, and gradually expanding comfort with new ideas—thereby enhancing human creativity without drugs. By personalizing AI systems to each person’s personality type and gradually increasing novelty levels, these tools could make creative thinking accessible to people who might not naturally gravitate toward it.

Read More »

The therapeutic potential of microdosing psychedelics in depression

This review examines whether taking very small doses of psychedelic drugs like LSD and psilocybin might help treat depression. While users report benefits and some studies show subtle positive effects on mood and thinking, scientists have not yet confirmed whether microdosing actually works as a depression treatment. More research with depressed patients is needed to understand if this approach is truly helpful and safe for regular use.

Read More »

Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models

This research shows that overweight and obese individuals have higher levels of a toxic compound called quinolinic acid in their bodies, which is linked to memory problems and brain shrinkage. The good news is that butyrate, a substance naturally produced by gut bacteria when we eat fiber, can protect against these harmful effects. Butyrate works by activating genes that produce brain-derived neurotrophic factor (BDNF), a protein essential for brain health and memory formation. The study suggests that increasing butyrate through diet or supplements could help prevent cognitive decline associated with obesity.

Read More »
Scroll to Top